Synmosa Biopharma Corporation at its 2023 special shareholders meeting held on July 13, 2023, approved the appointment of Tu, San-Chien as additional independent director. Resume of the new position holder: Director, Pang Kuei Accounting Firm; Independent Director, Lin BioScience Inc.; Independent Director, SINMAG EQUIPMENT CORPORATION; Independent Director, DAH CHUNG BILLS FINANCE CORP.; and Supervisor, JORJIN TECHNOLOGIES INC. Effective date of the new appointment: July 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.55 TWD | +1.15% | +2.06% | +2.33% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.33% | 465M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director